Schedule 13D ownership disclosure

HUMACYTE INC

Security class unavailable · CUSIP: 44486Q103

Event date: 2024-05-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
9,186,901
Percent of class
7.6000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001818382-24-000085
Form type
SC 13D/A
Filer
Humacyte, Inc.
CIK
CIK 1818382
Filed
Jun 04, 2024
Reporting period
May 31, 2024
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub

SC 13D/A | SEC Filings Hub